Public research preview

Lisa McClain, Representative disclosure: Novo Nordisk A/S Common Stock (NVO)

Disclosed a buy transaction in Novo Nordisk A/S Common Stock (NVO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
66/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
22 Oct 2025, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
41 days

Timeline

Transaction date

11 Sept 2025

Public disclosure

22 Oct 2025

Now

Tracked today

Filing delay: 41 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
13 Jul 2026

Most of the move happened before this disclosure became public: the stock peaked +13.9% above the transaction-date close and has since retraced -13.7% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.

Stock path

NVO from pre-transaction context through latest close.

Bought

11 Sept 2025 · 52.379 USD · Not public yet

System decision

Would have bought · Discount entryThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 22 Oct 2025 at 51.492 USD. Since entry: -4.3%. Planned exit on 19 Nov 2025 after 20 trading days.

Not public yetWindow closed34.848.261.7USDDate11 Sept22 Oct13 JulOfficial disclosure22 OctPlanned exit51.5System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
52.379
Observed disclosure close
51.492
Observed latest close
49.3
Pre-disclosure move
-1.7%
Post-disclosure move
-4.3%
Market-adjusted move
-17.5%
1w since disclosure
-3.8%
1m since disclosure
-10.8%
3m since disclosure
+13.7%
Pre-disclosure peak run-up
+13.9%
Retrace from peak
-13.7%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 22 Oct 2025, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerNVO
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032129.pdf
personNameLisa McClain
amountRange$1,001 - $15,000
companyNameNovo Nordisk A/S Common Stock (NVO)
publishedAt2025-10-22T00:00:00.000Z
rawDocumentIdraw-us-house-20032129-66
disclosureDate2025-10-22
transactionDate2025-09-11
transactionTypeP